Apixaban versus warfarin for anticoagulation after left ventricular assist device implantation: A multicenter real-world analysis

Anticoagulation is standard in patients with left ventricular assist devices (LVADs), but the optimal regimen remains uncertain. While warfarin has historically been utilized, the use of direct oral anticoagulants is increasing. Using the TriNetX Collaborative Research Network, we identified adult H...

Descripció completa

Dades bibliogràfiques

Autors principals:	Vien T. Truong, MD, Giorgi Chilingarashvili, MD, Avilash Mondal, MD, Timothy Raymond, MD, Si Pham, MD, Thomas O'Brien, MD, Eugene S. Chung, MD, Gregory F. Egnaczyk, MD, PhD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-08-01
Col·lecció:	JHLT Open
Matèries:	left ventricular assist device HeartMate 3 warfarin direct oral anticoagulants apixaban
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2950133426000881
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!